EU approves 1.8 billion doses vaccine contract with BioNTech-Pfizer

The European Union (EU) is making ready to offer new vaccines.

Ursula von der Leyen, President of the EU Fee, introduced on her social media account {that a} new contract was signed with BioNTech-Pfizer for the acquisition of coronavirus vaccine.

1.8 BILLION DOSE PURCHASE CONTRACT

Declaring that the vaccination course of is progressing nicely in Europe, Von der Leyen said that extra doses will likely be utilized in immune-boosting vaccines, within the combat in opposition to rising new variants, and within the vaccination of kids and younger individuals.

Von der Leyen famous that the EU Fee has permitted a purchase order contract with BioNTech-Pfizer for a complete of 1.8 billion doses for the years 2021-2023, with 900 million doses non-obligatory.

VACCINE AGREEMENTS

So far, the EU has contracts, together with choices, to obtain 2.4 billion doses of vaccine with BioNTech-Pfizer, 400 million with AstraZeneca, 300 million with Sanofi-GSK, 400 million with Johnson & Johnson, 405 million with CureVac, 460 million doses with Moderna. .

To this point, vaccines produced by BioNTech-Pfizer, Moderna, AstraZeneca and Johnson & Johnson corporations have obtained EU approval.

Contemplating these conventions, the EU administration goals to vaccinate 70 p.c of the grownup inhabitants within the EU with a inhabitants of 450 million in summer time.